Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATF4 | P18848 | 14/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23773097 | 0.94 | ATF4 (0.49) | ATF4MEN1KMT2A | |
| SCHEMBL23753564 | 0.92 | ATF4 (0.67) | ATF4MEN1ALDH1A1KMT2AL3MBTL1 | |
| SCHEMBL23773086 | 0.91 | ATF4 (0.56) | ATF4 | |
| SCHEMBL23773229 | 0.89 | ATF4 (0.54) | ATF4 | |
| SCHEMBL23773253 | 0.87 | ATF4 (0.56) | ATF4MEN1KMT2A | |
| SCHEMBL23773299 | 0.87 | ATF4 (0.56) | ATF4L3MBTL1 | |
| SCHEMBL23773390 | 0.85 | ATF4 (0.58) | ATF4 | |
| SCHEMBL23773235 | 0.85 | ATF4 (0.55) | ATF4 | |
| SCHEMBL23773305 | 0.84 | ATF4 (0.55) | ATF4MEN1KMT2A | |
| SCHEMBL19569429 | 0.83 | ATF4 (0.82) | ATF4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210253528-A1 | CHEMICAL COMPOUNDS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2021-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210253528-A1 | CHEMICAL COMPOUNDS | ATF4, EIF2AK4, ATF1 | ATF4 1/4885MEN1 3941/4885ALDH1A1 3644/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.